Speech Learning and Speech Production in Parkinson's Disease
Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. By linking these two abilities in individuals with Parkinson's disease using a precision medicine approach, this project seeks to build a basis for new therapies that help people with Parkinson's disease both understand better and speak more clearly.
Study identifier: NCT07403539. Status: RECRUITING. Phase: NA.
Eligibility
Criteria: Inclusion Criteria: * Diagnosis of Parkinson's disease * Native speaker of North American English * Use a drug that includes levodopa * Resident of the United States Exclusion Criteria: * Any history of language, hearing or speech disorder outside of Parkinson's disease * Other gross neurological impairment such as Alzheimer's disease or stroke * Significant hearing loss and/or use of a hearing aid or cochlear implant
- Minimum age: 45 Years
Participating locations
- State University of New York at Buffalo, Buffalo, New York
Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.